Currently, there are 1.17B common shares owned by the public and among those 1.16B shares have been available to trade.
The company’s stock has a 5-day price change of 2.91% and -21.78% over the past three months. BEKE shares are trading -6.05% year to date (YTD), with the 12-month market performance up to 1.74% higher. It has a 12-month low price of $12.44 and touched a high of $20.48 over the same period. BEKE has an average intraday trading volume of 7.65 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 8.77%, 3.26%, and 2.35% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of KE Holdings Inc ADR (NYSE: BEKE) shares accounts for 44.59% of the company’s 1.17B shares outstanding.
It has a market capitalization of $17.75B and a beta (3y monthly) value of -0.75. The stock’s trailing 12-month PE ratio is 31.36, while the earnings-per-share (ttm) stands at $0.49. The company has a PEG of 17.92 and a Quick Ratio of 1.63 with the debt-to-equity ratio at 0.29. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.26% over the week and 3.42% over the month.
Earnings per share for the fiscal year are expected to decrease by -11.60%, and 14.79% over the next financial year.
Looking at the support for the BEKE, a number of firms have released research notes about the stock. New Street stated their Buy rating for the stock in a research note on May 09, 2023, with the firm’s price target at $22. JP Morgan was of a view on January 30, 2023 that the stock is Overweight, while JP Morgan gave the stock Overweight rating on January 12, 2023, issuing a price target of $17- $21. HSBC Securities on their part issued Buy rating on June 23, 2022.
